Actively Recruiting
Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
Led by Universitair Ziekenhuis Brussel · Updated on 2024-11-01
40
Participants Needed
2
Research Sites
65 weeks
Total Duration
On this page
Sponsors
U
Universitair Ziekenhuis Brussel
Lead Sponsor
V
Vrije Universiteit Brussel
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study looks into how a common breast cancer treatment, paclitaxel, can sometimes cause severe side effects that make it hard for patients to continue treatment. These side effects can significantly affect a patient's quality of life and even impact their recovery and overall health costs. What's interesting about this research is that it considers how a patient's lifestyle, specifically their physical activity levels and body makeup (like how much muscle and fat they have), might influence these side effects. The researchers are doing a detailed study with 40 women receiving paclitaxel treatment, tracking how the drug is processed in their bodies and how their body composition and physical activity might play a role in the side effects they experience. They are using a special method to monitor drug levels in the blood and are also keeping tabs on the patients' health and physical activity through questionnaires and modern tracking devices. The goal here is twofold: first, to better understand why these side effects happen to some people and not others, and second, to develop a model that can predict who might be at higher risk for these side effects based on their body composition, lifestyle, and how their body handles the drug. This could lead to more personalized treatment plans that could help reduce the risk of severe side effects and improve the overall treatment experience for patients with breast cancer. In simpler terms, this research is trying to find a way to make breast cancer treatment with paclitaxel safer and more comfortable by considering how a person's lifestyle and body type might affect their reaction to the drug. This could make a big difference in helping patients complete their treatment successfully and with a better quality of life.
CONDITIONS
Official Title
Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients diagnosed with stage II or III breast cancer
- Planned to receive 12 cycles of paclitaxel chemotherapy in a (neo-)adjuvant setting
- Age 18 years or older, including pre- and post-menopausal women
- Prior taxane treatment allowed if completed more than one year ago
You will not qualify if you...
- Cognitive impairment that prevents understanding of study instructions
- Participation in clinical trials of experimental drugs
- Documented intolerance or allergy to paclitaxel
- Use of medications that interact with paclitaxel
- Male sex
- Age under 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
UZ Brussel
Brussels, Jette, Belgium, 1090
Actively Recruiting
2
Vrije Universiteit Brussel
Brussels, Jette, Belgium, 1090
Not Yet Recruiting
Research Team
L
Len De Nys
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here